P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES
Sparad:
| Huvudupphov: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wiley
2023-05-01
|
| Serie: | HemaSphere |
| Länkar: | http://journals.lww.com/10.1097/01.HS9.0000936352.84768.4d |
| Taggar: |
Inga taggar, Lägg till första taggen!
|